Gleiss, Andreas; Frass, Michael; Gaertner, Katharina (2016). Re-analysis of survival data of cancer patients utilizing additive homeopathy. Complementary therapies in medicine, 27, pp. 65-67. Elsevier 10.1016/j.ctim.2016.06.001
![[img]](https://boris.unibe.ch/style/images/fileicons/text.png) |
Text
2016_Gleiss, Frass, Gaertner_Re-analysis of survival data of cancer patients utilizing additive homeopathy.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (344kB) |
In this short communication we present a re-analysis of homeopathic patient data in comparison to control patient data from the same Outpatient's Unit "Homeopathy in malignant diseases" of the Medical University of Vienna. In this analysis we took account of a probable immortal time bias. For patients suffering from advanced stages of cancer and surviving the first 6 or 12 months after diagnosis, respectively, the results show that utilizing homeopathy gives a statistically significant (p<0.001) advantage over control patients regarding survival time. In conclusion, bearing in mind all limitations, the results of this retrospective study suggest that patients with advanced stages of cancer might benefit from additional homeopathic treatment until a survival time of up to 12 months after diagnosis.
Item Type: |
Journal Article (Original Article) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Medical Education > Institute of Complementary and Integrative Medicine (IKIM) |
UniBE Contributor: |
Gaertner, Katharina Ursula |
Subjects: |
600 Technology > 610 Medicine & health |
ISSN: |
0965-2299 |
Publisher: |
Elsevier |
Language: |
English |
Submitter: |
Martin Frei-Erb |
Date Deposited: |
29 Dec 2016 16:33 |
Last Modified: |
02 Mar 2023 23:28 |
Publisher DOI: |
10.1016/j.ctim.2016.06.001 |
PubMed ID: |
27515878 |
BORIS DOI: |
10.7892/boris.91080 |
URI: |
https://boris.unibe.ch/id/eprint/91080 |
Actions (login required)
 |
Edit item |